About Us

An innovative company.
A revolutionary technology for collection, storage and management of biological samples.


1CryoBio AG is a Swiss company with Danish background that develops, produces and markets innovative lab ware for cryogenic storage and handling of liquid samples. Our mission is to modernize the fast growing field of collection, storage and management of biological samples and provide solutions that do not exist so far.

Under private ownership and backed by renowned international investors, the company headquarters are located in Switzerland, at the D4 Technopark, close to Lucerne.

Our first product, FlexiQuot, is the first of a series of new products made with a technology that can revolutionize the collection, handling and storage of samples. More variants of FlexiQuot as well as new exciting products like ICENESS are in the pipeline to address the constantly evolving needs of labs to reduce costs and improve workflow efficiency and sample quality.

Our Vision

Better healthcare and research through better biological samples

Our Mission

Take collection, handling and management of biological samples to the next level


Bruno Ehrler, CEO

Before stepping into his role as Chief Executive Officer of 1CryoBio AG, Bruno Ehrler practiced as an Industrial Engineer and Six Sigma Voice-of-the-Customer Champion in several industries. He has held full responsibility for multi-million dollar projects executed with international cross-functional teams. In addition, Bruno holds an MBA from the University of St. Gallen, brings experience of start-up businesses and has proven his leadership in various fields.
Bruno Ehrler on LinkedIn.


Ove Andersen, MD, PhD, CSO

Dr. Andersen is a specialist in Internal Medicine and Infectious Diseases and serves Clinical Associate Professor at Copenhagen University. Dr. Andersen is also Head of the Clinical Research Centre at the Copenhagen University Hospital Hvidovre. Dr. Andersen is co-author of more than 90 scientific publications and is inventor and co-inventor of four patents, several products based on which have reached the market. Dr. Andersen has commercialization experience as founder of Profylakse Aps and Oracain Aps, were he was in charge of scientific and clinical studies, with responsibility for management and design of trials, product design and overall co-ordination of the development programs.
Ove Andersen on LinkedIn.


Georgios Georgopoulos, Business Development Director

Georgios has studied Physics at the Univerity of Athens and holds an MBA from the University of St. Gallen. He has long experience in sales and marketing in various fields of the life sciences industry (diagnostics, pharma, biotech, med-tech) and in several company types (SME’s, startups, global corporations). In 1CryoBio Georgios is, among others, in charge of the commercial operations of the company.
Georgios Georgopoulos on LinkedIn.


John Reddington, PhD

Dr. Reddington, CEO and President Morris Foundation, one of the largest promoters of research to the benefit of animals, has started and managed private and public biotech companies for almost 25 years. Most recently, he served as COO of Cambridge Biomedical (US), and President and CEO of Sirtex Medical (Australia), where he reorganized and revitalized the US division.
John Reddington on LinkedIn.


Edward C. Cappabianca

Mr. Cappabianca is CEO of EnXray Limited and Managing Director at CapeWhite Consulting Ltd. His previous experience includes CEO of AmpliPhi Biosciences Corporation and over 20 years as an investment banker with leading firms, including Alex, Brown & Sons, William Blair & Co, and Rodman & Renshaw LLC.
Edward Cappabianca on LinkedIn.


Otto Skolling

Mr. Skolling holds a MSc in chemistry, with 20 years of pharma and Medtech industry experience gained at Novozymes, Siemens Life Support Systems, Pharmacia & Upjohn and lately as VP Business Development at Karolinska Development AB.
Otto Skolling on LinkedIn.

Board of Directors

Dr. Jørgen Thorball, MD, Chairman

Dr. Thorball started his career in international corporate management positions in the pharmaceutical industry (Pharmacia and Aventis) where he had global product responsibility. As Managing Partner in XOventure GmbH he subsequently built more than 30 life science companies and led a series of merger and acquisition transactions, as well as business development innovations. In 2010, Jørgen Thorball was awarded the Medicon Valley Cross Border Award for his achievements.
Jørgen Thorball on LinkedIn.


Bruno Odermatt, Board Member, CFO

Mr. Odermatt is founder of and partner at Value Solutions Group. His previous experience includes serving as Head of Center of Competence Valuation and Member of the Managing Team for Corporate Finance/Corporate Recovery at KPMG and CFO at Prionics, as well as a number of board and management positions.
Bruno Odermatt on LinkedIn.
Visit Our Office

1CryoBio AG, Platz 4, 6039 Root D4, Switzerland

Call Our Office

+41 41 541 92 00

Email Us